Breast MRI Spectroscopy
Our aim is to perform MR Spectroscopy (MRS) on 150 evaluable patients at the end of their
routine breast MRI examination using a software package from General Electric Medical
Systems Milwaukee, WI). This will add time to the routine examination but will not involve
additional injections of contrast. We will analyze the spectroscopic data to determine if
benign lesions can be reliably differentiated from malignant ones.
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
To determine if spectroscopy of the breast can be performed and can be functional in a clinical environment.
Sandra Brennan, MD
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
|Memorial Sloan Kettering Cancer Center||New York, New York 10021|